Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - tolcapone 100mg - film coated tablet - 100 mg - active: tolcapone 100mg excipient: calcium hydrogen phosphate ethylcellulose hypromellose iron oxide yellow lactose monohydrate magnesium stearate microcrystalline cellulose povidone purified talc   sodium laurilsulfate sodium starch glycolate titanium dioxide triacetin - tasmar is indicated for use in combination with levodopa/benserazide and levodopa/carbidopa in parkinson's disease, including both fluctuating and non-fluctuating patients.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - abacavir sulfate 351mg equivalent to 300 mg abacavir;  ;   - film coated tablet - 300 mg - active: abacavir sulfate 351mg equivalent to 300 mg abacavir     excipient: colloidal silicon dioxide magnesium stearate microcrystalline cellulose opadry yellow ys-1-12789-a purified water sodium starch glycolate - ziagen is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and children.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - abacavir sulfate 23.4 mg/ml equivalent to 20 mg/ml abacavir base.;  ;   - oral solution - 20 mg/ml - active: abacavir sulfate 23.4 mg/ml equivalent to 20 mg/ml abacavir base.     excipient: banana flavour 59.256 ap0551 citric acid hydrochloric acid methyl hydroxybenzoate propyl hydroxybenzoate propylene glycol purified water saccharin sodium sodium citrate dihydrate sorbitol strawberry flavour 057883 ap0551 - ziagen is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and children.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

abbvie limited - levobunolol hydrochloride 0.5%{relative};  ;  ;   - eye drops, solution - 0.5 % - active: levobunolol hydrochloride 0.5%{relative}       excipient: benzalkonium chloride dibasic sodium phosphate heptahydrate disodium edetate hydrochloric acid monobasic potassium phosphate polyvinyl alcohol purified water sodium chloride sodium hydroxide sodium metabisulfite

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

viatris limited - verapamil hydrochloride 40mg;   - film coated tablet - 40 mg - active: verapamil hydrochloride 40mg   excipient: calcium hydrogen phosphate dihydrate colloidal silicon dioxide croscarmellose sodium hypromellose macrogol 6000 magnesium stearate microcrystalline cellulose purified talc sodium laurilsulfate titanium dioxide - · essential hypertension

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

viatris limited - verapamil hydrochloride 80mg;   - film coated tablet - 80 mg - active: verapamil hydrochloride 80mg   excipient: calcium hydrogen phosphate dihydrate colloidal silicon dioxide croscarmellose sodium hypromellose macrogol 6000 magnesium stearate microcrystalline cellulose purified talc sodium laurilsulfate titanium dioxide - · essential hypertension

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - ketoconazole 20.6 mg/ml;  ;  ;   - shampoo - 2% w/w - active: ketoconazole 20.6 mg/ml       excipient: cocamide diolamine diazolidinyl urea erythrosine hydrochloric acid herb flower fragrance polyethylene glycol distearate purified water sodium laureth sulfate sodium lauril sarcosinate - treatment of seborrhoeic dermatitis and severe dandruff of the scalp in adults.

Bretland - enska - myHealthbox

piramal healthcare uk limited - desflurane - inhalation vapour liquid - 100% (v/v) - nervous system; anesthetics; general; halogenated hydrocarbons - it is indicated as an inhalation agent for induction and maintenance of general anesthesia for inpatient and outpatient surgery in adults and for the maintenance of anaesthesia in infants and children.

Bandaríkin - enska - NLM (National Library of Medicine)

proficient rx lp - baclofen (unii: h789n3fke8) (baclofen - unii:h789n3fke8) - baclofen tablets usp are useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. patients should have reversible spasticity so that baclofen treatment will aid in restoring residual function. baclofen tablets usp may also be of some value in patients with spinal cord injuries and other spinal cord diseases. baclofen tablets usp are not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders. the efficacy of baclofen in stroke, cerebral palsy, and parkinson’s disease has not been established and, therefore, it is not recommended for these conditions. hypersensitivity to baclofen.  safety and effectiveness in pediatric patients below the age of 12 years have not been established.